首頁
1
衛教資訊
2
藥物測試研究
3
NF國際醫療測試研究 - 14
http://www.nf.org.tw/custom_32016.html NF國際醫療測試研究 - 1 NF國際醫療測試研究 - 1 症狀 醫療測試方法  測試期別 Neurofibromatosis Type 1 Drug: Lamotrigine Phase 2 Cognition Drug: Placebo Phase 3 Neurofibromatosis Type 1 Drug: methylphenidate Phase 4 ADHD  Neurofibromatosis Type 1 Drug: Lovastatin ™ Phase 2 attention deficits, memory  Device: placebo  Neurofibromatosis Type 1 Drug: Sirolimus, Rapamycin Phase 2 Progressive plexiform neurofibroma(s)   Neurofibromatosis Type 1 Drug: pirfenidone Phase 1 Precancerous Condition  Plexiform Neurofibroma Associated With Neurofibromatosis Type 1  Drug: Everolimus Phase 4 NF1 Drug: Cabozantinib Phase 2 Neurofibromatosis Plexiform Neurofibromas  Neurofibromatosis Type I Drug: Nexavar (BAY 43-9006) (Sorafenib) Phase 1 Plexiform Neurofibroma Drug: Toxicity, Pharmacokinetics   Drug: Pharmacodynamics   Drug: Radiographic Evaluation   Drug: QOL assessment, Neuropsychological   Drug: Bony Toxicity 在本網頁提供的資料僅供參考,並非對醫療上的建議,也不構成上市臨床活動的認可。以上是美國和歐洲的資訊來源所整理的醫療試驗。 李銘仁整理 2015-12-07                

號外號外~恭喜!!優秀的病友學子們得到罕病協會的【優秀獎助學金】

首頁 衛教資訊 > 藥物測試研究 > NF國際醫療測試研究 - 1

症狀 醫療測試方法  測試期別
Neurofibromatosis Type 1 Drug: Lamotrigine Phase 2
Cognition Drug: Placebo Phase 3
Neurofibromatosis Type 1 Drug: methylphenidate Phase 4
ADHD 
Neurofibromatosis Type 1 Drug: Lovastatin ™ Phase 2
attention deficits, memory  Device: placebo 
Neurofibromatosis Type 1 Drug: Sirolimus, Rapamycin Phase 2
Progressive plexiform neurofibroma(s)  
Neurofibromatosis Type 1 Drug: pirfenidone Phase 1
Precancerous Condition 
Plexiform Neurofibroma Associated With Neurofibromatosis Type 1  Drug: Everolimus Phase 4
NF1 Drug: Cabozantinib Phase 2
Neurofibromatosis
Plexiform Neurofibromas 
Neurofibromatosis Type I Drug: Nexavar (BAY 43-9006) (Sorafenib) Phase 1
Plexiform Neurofibroma Drug: Toxicity, Pharmacokinetics
  Drug: Pharmacodynamics
  Drug: Radiographic Evaluation
  Drug: QOL assessment, Neuropsychological
  Drug: Bony Toxicity

網頁提供的資料僅供參考,並非醫療上的建議,也不構成上市臨床活動的認可。以美國和歐洲的資訊來源所整理的醫療試驗

李銘仁整理 2015-12-07